Shinpoong to activate anti-malaria drug development.

Shinpoong signed an agreement with WHO-MMV at Marriot hotel in Seoul on Oct. 15 for a joint development of Pyronaridine artesunate, an anti-malaria drug. When successfully developed, WHO-MMV will be responsible for the world product registration whereas Shinpoong supplies the product.

Shinpoong took part in the world's anti-malaria projects over the world jointly with WHO and UNICEF under ...